Recently, Exploration of Targeted Anti-tumor Therapy (ETAT) successfully promoted its academic influence and appeal at two major neurosurgery conferences.

On September 5–6, 2025, the Academic Annual Meeting of the Neurosurgical Oncology Professional Committee of Guangdong Medical Association and the Southern Guangdong Neurosurgical Forum was held in Guangzhou, China. This was followed by the 11th Academic Congress in Changsha, China, from September 12-14. During these events, Prof. Chunsheng Kang, a member of ETAT’s editorial board, was invited to give keynote presentations.

In his presentation, Prof. Kang provided an in-depth explanation of the journal’s academic positioning, scope, editorial board, database inclusion, and impact indicators. He emphasized ETAT’s role as a premier gold open-access journal, highlighting its platform in aggregating global research findings on targeted tumor therapies.

This series of academic promotions has raised ETAT’s visibility among neurosurgical oncology and related clinical medical researchers. It has created favorable conditions for attracting high-quality submissions and fostering deeper international academic exchanges. Moving forward, ETAT will continue to build a high-level platform for academic communication, collaborating with global scholars to advance innovation and development in the field of targeted anti-tumor therapies.